High-Risk Polymorphisms Associated with the Molecular Function of Human HMGCR Gene Infer the Inhibition of Cholesterol Biosynthesis

Das, Keshob Chandra; Hossain, Mohammad Uzzal; Moniruzzaman, Md; Salimullah, Md; Akhteruzzaman, Sharif

doi:https://doi.org/10.1155/2022/4558867

BioMed Research International

On this page

Abstract Introduction Materials and Methods Results Discussion Conclusion Abbreviations Data Availability Conflicts of Interest Authors’ Contributions Acknowledgments References Copyright Related Articles

Research Article | Open Access

Volume 2022 | Article ID 4558867 | https://doi.org/10.1155/2022/4558867

High-Risk Polymorphisms Associated with the Molecular Function of Human HMGCR Gene Infer the Inhibition of Cholesterol Biosynthesis

Keshob Chandra Das,¹Mohammad Uzzal Hossain,^2,3Md Moniruzzaman,¹Md Salimullah,¹and Sharif Akhteruzzaman⁴

Academic Editor: Bing Wang

Received26 Nov 2021

Accepted13 May 2022

Published06 Jun 2022

Abstract

HMG-CoA reductase or HMGCR (3-hydroxy-3-methylglutaryl-CoA reductase) is a rate-limiting enzyme involved in cholesterol biosynthesis. HMGCR plays an important role in the possible occurrence of hypercholesterolemia leading to atherosclerosis and coronary heart disease. This enzyme is a major target for cholesterol-lowering drugs such as “statin” which blocks the synthesis of mevalonate, a precursor for cholesterol biosynthesis. This study is aimed at characterizing deleterious mutations and classifying functional single nucleotide polymorphisms (SNPs) of the HMGCR gene through analysis of functional and structural evaluation, domain association, solvent accessibility, and energy minimization studies. The functional and characterization tools such as SIFT, PolyPhen, SNPs and GO, Panther, I-Mutant, and Pfam along with programming were employed to explore all the available SNPs in the HMGCR gene in the database. Among 6815 SNP entries from different databases, approximately 388 SNPs were found to be missense. Analysis showed that seven missense SNPs are more likely to have deleterious effects. A tertiary model of the mutant protein was constructed to determine the functional and structural effects of the HMGCR mutation. In addition, the location of the mutations suggests that they may have deleterious effects because most of the mutations are residing in the functional domain of the protein. The findings from the analysis predicted that rs147043821 and rs193026499 missense SNPs could cause significant structural and functional instability in the mutated proteins of the HMGCR gene. The findings of the current study will likely be useful in future efforts to uncover the mechanism and cause of hypercholesterolemia. In addition, the identified SNPs of HMGCR gene could set up a strong foundation for further therapeutic discovery.

1. Introduction

Hypercholesterolemia, or elevated blood cholesterol levels, is a condition associated with an increased risk of atherosclerosis and coronary heart disease [1]. These cardiovascular diseases are the result of elevated serum non-high-density lipoprotein cholesterol (non-HDLC) levels. The variations in non-HDL cholesterol among individuals are a result of disparities among the genes involved in the biosynthesis of cholesterol as well as environmental factors such as diet and lifestyle [2–4]. Cholesterol is one of the three major classes of lipids; the complex procedure of cholesterol biosynthesis is essential for all animal life. The process of cholesterol biosynthesis begins with the mevalonate pathway, and the rate-limiting enzyme of this pathway is called 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase (HMG-CoA reductase or HMGCR) [5, 6].

HMGCR is regulated via a negative feedback mechanism mediated by sterols and nonsterol metabolites derived from mevalonate. Normally, cholesterol produced from the internalization and degradation of low-density lipoprotein (LDL) via the LDL receptor suppresses the activity of this enzyme in mammalian cells. The expression of LDL receptors in the liver is induced by competitive inhibitors of the reductase, which in turn upsurges the catabolism of plasma LDL and lessens the plasma concentration of cholesterol, an important factor of atherosclerosis [7–11]. Thus, HMGCR serves as a target for the cholesterol-lowering drug, statin. Statins are a class of drugs that act as competitive inhibitors of the enzyme. The inhibition of the enzyme by the drug reduces the rate by which HMGCR can produce mevalonate, the next molecule in the cascade that eventually produces cholesterol. This is significant because most circulating cholesterol comes from internal manufacture rather than a diet. When the liver can no longer produce cholesterol, the liver cells begin to express LDL receptors on their surface, which bind LDL cholesterol particles and internalize them and the levels of cholesterol in the blood will fall [12]. Despite the fact that statin medicines are effective at decreasing cholesterol, the patient’s response to them varies greatly among individuals [13, 14]. Several pharmacogenetics investigations and genome-wide association studies (GWAS) have revealed genetic variants in genes involved in cholesterol homeostasis as a significant contributor of the diversity in statin response reported among patients [15–17]. These studies have shown that the SNPs (single nucleotide polymorphisms) are related to not only the therapeutic effect of statin but also blood lipid level, consequently the risk of developing cardiovascular disease [18–20].

Functional genomics and mutational analysis with the advancement of bioinformatics tools have already provided the key advances in disease diagnosis, prognosis, and therapeutic efficacy [21–35]. The mutational effect upon the protein structure and disease prognosis has been identified by the in silico techniques which further could be validated by the wet lab research [36–42]. However, the in silico analysis of coding SNPs of the HMGCR gene is still yet to be explored to observe the mutational effect. Among which missense coding SNPs are thought to have the principal impact on phenotype and may exert deleterious effects on the structure, function, solubility, or stability of proteins. Hence, this investigation is aimed at characterizing the deleterious mutations of HMGCR gene. Our study involved the following: (a) retrieval of SNPs in the HMGCR gene from available databases, (b) detecting deleterious missense SNPs that can change splicing and gene expression patterns using sequence- and structure-based homology search, (c) predicting the precise effects of the substitutions of amino acids on secondary structures via solvent accessibility and stability of the structure, and (d) prediction of change in the domain constructions due to the mutations. This study is the first extensive in silico analysis of the HMCGR gene and expected to establish a strong foundation for structure-function relationship of the enzyme and population-specific variation studies in years to come. Further, it might explore the specific mutation-based drug discovery against hypercholesterolemia.

2. Materials and Methods

2.1. Retrieval of SNP Datasets

SNP of the HMGCR gene and their protein sequences (FASTA format) were retrieved from the dbSNP database (http://www.ncbi.nlm.nih.gov/SNP/) for computational analysis. Various filters were used for the selection of SNPs related to HMGCR, such as missense, inframe deletion, inframe insertion, initiator codon variant, and synonymous.

2.2. Analysis of Functional Consequences of Missense SNPs

Sorting Intolerant from Tolerant (SIFT) [43] is an algorithm that predicts the potential impact of amino acid substitutions on protein function. This program assumes that evolutionarily conserved regions tend to be less tolerant of mutations, and hence, amino acid substitutions or insertions/deletions in these regions are more likely to affect function [43]. SIFT considers the composition of amino acids and calculates the score after searching a query protein against a protein database to obtain homologous protein sequences. All the retrieved mutations were submitted to this tool. A SIFT score ranges from 0 to 1; it is a standardized probability of perceiving the new amino acid at that position. It also calculates the tolerance index (TI) of a particular amino acid substitution. SIFT score is classified as tolerant (ranging from 0.201 to 1.00) or intolerant (0.051–0.10) and borderline (0.101–0.20). Hence, an SNP’s functional consequence is inversely proportional to the tolerance index (TI) [44]. In this study, the reference SNP cluster identification (rsID) of each SNP of human HMGCR gene obtained from NCBI was submitted as a query sequence to SIFT for homology searching. The SIFT score of ≤0.05 indicates the deleterious effect of missense variants on protein function.

2.3. Functional Consequences of Missense SNPs by Structural Homology

To comprehend the functional significance of a protein, it is essential to scrutinize the damaged coding missense SNPs at the structural level. Polymorphism Phenotyping-2 or PolyPhen-2 [45] is an automatic tool for the prediction of the possible impact of an amino acid substitution on the structure and function of a human protein. To understand the functional consequence, the protein sequence of our gene along with mutational position and two amino acid variants was submitted as the query. The PolyPhen-2 calculates the posterior probability that a missense SNP is damaging by a Bayesian classifier [46]. The conservation of a position in the MSA and the deleterious effect on the protein structure results in the Position-Specific Independent Count (PSIC) score that ranges from 0 to 1 [45]. The categorization of the missense SNPs results in possibly damaging and probably damaging () or benign (). PolyPhen-2 predicts the possible functional impact of the SNPs on structure based on the difference of the PSIC score.

2.4. Characterization of Functional Missense SNPs

SNP&GO (Gene Ontology) [47, 48] was used for the characterization of functional missense SNPs. The impact of protein variations was predicted via the SNP&GO algorithms, using functional information categorized by GO terms of the three main roots: molecular function, biological process, and cellular component. The selected SNPs were submitted into this tool to determine the functional insights. The sequence profile is then calculated by performing one run of BLAST against the UniRef90 dataset to select homologous sequences with an value lower than 10^-9. The algorithm uses a support vector machine (SVM) based analyzing method, which includes the sequence environment of the variation and a log-odd score calculated considering all the Gene Ontology terms connected to the mutated protein and their parents in the GO graph. A probability score higher than 0.5 reveals the disease-related effect of mutation on the protein function [48].

PANTHER cSNP (Protein ANalysis Through Evolutionary Relationship coding_SNP), the most popular online protein fold identification server, calculates the likelihood of a single AA change on protein function, and it is based on the PANTHER-PSEP (Position_Specific Evolutionary Preservation) method [49]. PMUT is based on the use of different kinds of sequence information to label mutations and neural networks to process this information. FASTA sequence was inputted, and result was based on the differences among disease related and neutral variations of protein sequence. Probability score higher than 0.5 reveals the disease-related effect of mutation on the protein function [50]. MutPred2 is a machine learning-based method and software package that integrates genetic and molecular data to reason probabilistically about the pathogenicity of amino acid substitutions [51]. MutPred2 was utilized to predict the pathogenicity of all the nsSNPs of the HMGCR gene. Finally, SNAP-2 uses neural networks to anticipate the impact of single amino acid substitutions (SNPs). Prediction scores are visualised as a heat map [51].

2.5. Prediction of Modification in Stability upon Mutation

To predict the change in stability owed to mutations, the I-Mutant 2.0 server was used. This is a support vector machine (SVM) based tool server, which analyzes the structure or the sequence of the protein. I-Mutant 2.0 is a classifier that can automatically predict the change in protein structural stability upon mutations, and it also acts as a regression estimator which predicts the change in Gibbs free energy differences between the mutated and wild-type protein in kcal/mol [52].

2.6. Missense SNP in Functional Region

The Pfam server was used to discern the location of missense SNP into the functional region in protein structure. This is a database of protein families, their annotations, and multiple sequence alignments, which provides a complete and accurate classification of protein families and domains [53]. The identification of domains that occur within proteins can provide insights into their function; thus, Pfam was to analyze the functional region of the HMGCR.

2.7. Modeling of the Mutated Protein

Then, a Virtual Mutation (VM) procedure was applied to substitute amino acids in the atomic models [54]. Accelrys Discovery Studio 4.0 was then used to generate a mutated sequence for the corresponding amino acid substitutions [55]. The regenerated mutant sequences were used further for mutant modeling, which was performed through HHpred Modeller [56]. Later, the InterEvDock2 server was used to calculate the degree of evolutionary conservation at each amino acid position of the HMGCR protein [56]. HHpred chooses the best suitable template and generates a protein model through successive steps, such as profile construction, similarity analysis, and structural properties. Then, the Swiss model also confirmed the same template as HHpred Modeller selected [57]. A rigorous manner of protein modeling was nominated to get a perfect model.

2.8. Location and Structural Conformation of Mutations

We have utilized the STRIDE server to predict the mutational site upon the 3D structure. This server offers an interactive interface to the secondary structure assignment program STRIDE [58].

2.9. Molecular Dynamic Simulation

In order to evaluate the impact of the SNPs rs147043821 and rs193026499 on the stability of HMGCR gene product under physiological conditions, 50 ns molecular dynamic simulation was performed in using GROMACS (version 2021.1). The GROMOS9643a1 force field was applied on the protein-ligand complex [59]. The physiological condition of the system was defined (300 K, pH 7.4, 0.9% NaCl). The structures were solvated in a dodecahedral box of the SPC (simple point charge) water model with its edges at 1 nm distance from the protein surface. The overall charge of the system was neutralized using the genion module. Energy minimization of the neutralized system was carried out using the steepest descent minimization algorithm with maximum number of minimization steps to perform set at 50000. The ligand was restrained before carrying out the isothermal-isochoric (NVT) equilibration of the system for 100 ps with short-range electrostatic cutoff value of 1.2 nm. Isobaric (NPT) equilibration of the system was carried out for 100 ps following the NVT with short-range van der waals cutoff fixed at 1.2 nm. Finally, a 50 ns molecular dynamic simulation was run using periodic boundary conditions and time integration step of 2 fs. The energy of the system was saved every 100 ps. For calculating the long-range electrostatic potential, the Particle Mesh Ewald (PME) method was applied. Short-range van der waals cutoff was kept at 1.2 nm. The modified berendsen thermostat was used to control simulation temperature while the pressure was kept constant using the Parrinello-Rahman algorithm. The simulation time step was selected as 2.0 fs. The snapshot interval was set to 100 ps for analyzing the trajectory data. Finally, all of the trajectories were concatenated to calculate and plot root mean square deviation (RMSD), root mean square fluctuation (RMSF), radius of gyration (Rg), and solvent accessible surface area (SASA) data.

2.10. Data Analytics and Presentation

Figures and tables were used to present the results of our investigation. Based on the information from our results, the figures and tables were created using Excel, PowerPoint, and BioRender. The tools were also used to create the majority of the figures.

3. Results

The flowchart illustrates the overall procedure of identification and categorization of detrimental SNPs in HMGCR along with the structural and functional consequence analysis upon mutation (Figure 1).

3.1. HMGCR Gene Is Prone to Point Mutation and Rich in Missense Type

The HMGCR gene (25783 bp) consists of 23 exons. The SNP data for the HMGCR gene were collected from dbSNP as it contains the largest polymorphism database, despite housing both validated and nonvalidated polymorphism information [22]. The dbSNP contains a total of 6815 SNPs for the gene HMGCR where 388 SNPs were missense SNPs (Figure 2). Among 388 submitted missense SNP rsIDs from dbSNP, SIFT analyzed 7 missense SNPs to bear a deleterious effect with ; results are shown in Table 1. The corresponding 7 missense SNPs rs112503211, rs113949962, rs147043821, rs147818666, rs148335635, rs193026499, and rs368129510 had the tolerance index 0.1 and considered as damaging in the HMGCR gene (Table 1).

(a)

(b)

3.2. Coding Missense SNPs rs147043821 and rs193026499 are the Two Most Probable Damaging Mutations in HMGCR

The PolyPhen program was used to determine the missense SNPs with the potential to cause structural modifications due to the amino acid substitution. A total of 388 missense SNP rsIDs were submitted to the PolyPhen server, and in the resulting output, 27 amino acid substitutions have been reported to be probably damaging with a PSIC score ranging from 0.539 to 1. Seven missense SNPs (rs112503211, rs113949962, rs147043821, rs147818666, rs148335635, rs193026499, and rs368129510) were identified by SIFT as deleterious, also marked to be damaging by the PolyPhen-2 program as well (Table 2).

To further validate the results of the tools used beforehand, we analyzed the missense SNPs with the following in silico SNP prediction algorithms: PMUT, SNAP, PANTHER, MUTPRED, and SNP&GO. The missense SNPs which are marked as deleterious by both SIFT and PolyPhen-2 server were principally selected. The results generated from the abovementioned tools were further combined and compared with the result of SIFT and PolyPhen server. In the combined results of 388 missense SNPs, only 7 (rs114166108, rs113949962, rs182539049, rs145415894, rs142939718, rs35896902, and rs150721457) were predicted as disease related by at least 5 out of the 7 tools (Figure 3). Two missense SNPs, rs147043821 and rs193026499, showed positive results in all the 7 tools (Tables 3–7).

3.3. High-Risk Missense SNPs are Located in the Conserved Region

Biological processes rely on functional sites of proteins such as catalytic sites, allosteric sites, and protein-protein interaction sites. Amino acids present in these biologically active sites tend to be highly conserved, compared to any other residues in the protein. Any substitution of these residues generally leads to complete loss of biological functions and renders severe damaging effect to the biological process itself [25]. The retrieved amino acid sequence corresponding to missense SNPs was utilized to identify the suitable template to build the 3D structure. To predict the 3D structure, retrieved amino acid sequence was submitted to the NCBI protein BLAST tool to recognize the structure of the closest related proteins. The structure PDB ID: 3cd5 with 99.8% identity was selected and built 3D structure. InterEvDock2 identifies putative structural and functional residues and determines their evolutionary conservation [26]. Although a complete analysis was done, we focused on the conservation profile of the selected 7 high-risk missense SNP locations. The analysis showed that residues S147, M1, L218, G663, N204, R595, and R159 are highly conserved (Figure 4). These conserved residues in HMGCR might have imperative functional importance and are identified as functional or structural based on their location relative to the protein surface or the protein core.

3.4. High-Risk Missense SNPs are Capable of Inducing Protein Unfolding

The neural network-based routine tool I-Mutant 2.0 was used for examining the potential modifications in protein stability due to mutations. Models with the following mutations S147, M1, L218, G663, N204, R595, and R159 were submitted to the server for DDG stability prediction and RSA calculation. All the mutations decreased protein stability except rs113949962, which is shown to be increasing structural stability (0.58 kcal/mol). Mutation rs368129510 accounted for the lowest DDG value (−3.34 kcal/mol), meaning to be more unstable due to this mutation (Figure 5). All other mutations rs112503211, rs147043821, rs147818666, and rs193026499 have the DDG values, respectively, -0.88 kcal/mol, -1.27 kcal/mol, -0.67 kcal/mol, and -0.56 kcal/mol; this suggests decreased protein stability, due to DDG values being less than 0 (Figure 5). Further, we have also analyzed the surface accessibility surface area (SASA) and angles of the protein structure of alpha helix and beta sheet in both wild and mutant models of HMGCR. All the mutations reside in alpha helix and beta sheet which can induce the conformational change in protein (Table 8).

SASA may change due to mutation when the amino acid substitution occurred. Here, the SASA value has been changed in all the mutations except rs147818666. The SASA value of rs368129510 has been slightly decreased than the wild-type model. The increasing SASA value of the mutations rs147043821 and rs193026499 may lead to the unfolding of the protein 3D structure, meaning the loss of the biological functions of the HMGCR gene (Table 8).

3.5. High-Risk Polymorphisms Are Likely to Alter the Domain Structures of HMGCR

The PROSITE-ExPasy tool was used to search for domain structures in HMGCR and map the mutations in the domains for determining the changes they might cause in the domain structures. The tool searches the UNIProtKB database for motifs and in the produced result showed sterol-sensing domain (SSD) and hydroxymethylglutaryl-coenzyme A reductase (HMG-Co-A) domain in HMGCR. The SSD domain consists of 61–218 amino acid regions in the HMGCR gene, and HMG-Co-A is composed of 464–871 amino acid residues in the HMGCR region. All mutations S147, L218, G663, N204, R595, and R159C except 1MI are located in the SSD and HMG-Co-A domain (Figure 6).

3.6. Molecular Dynamic Simulation

Following 50 ns molecular dynamic simulation, RMSD, RMSF, Rg, and SASA calculations were carried out for the SNPs rs147043821 (Figure 7) and rs193026499 (Figure 8). RMSD analysis revealed that both rs147043821 and rs193026499 had a destabilizing effect on HMGCR. In both cases, the mutant exhibited higher structural deviation compared to the wild-type protein. Both the mutants rs147043821 and rs193026499 also showed regional flexibility as uncovered by the RMSF values. In terms of compactness, the SNP rs193026499 showed marked difference from its wild counterpart. The mutant remained in an unfolded state throughout the simulation while the wild type maintained a folded conformation. For the mutant rs147043821 however, the observed change in radius of gyration was not that drastic. SASA calculations indicated that the mutant rs193026499 introduced susceptibility to disruption by solvents. The mutant rs147043821 also followed the same trend, but its susceptibility became equivalent to the wild type near the end of the simulation.

4. Discussion

Single nucleotide polymorphisms (SNPs) are the main cause of most genetic diseases, because more than half of known genetic disorders involve amino acid substitutions. SNPs are exceptional genetic markers and play an important role in disease research because they are dispersed throughout the entire human genome. Although some disease-related SNPs are found in exons or coding regions, there are also SNPs that appear in the intronic regions of genes and interfere with regulatory regions, which in turn affect the splicing process and gene expression. Population-based surveys have become tough with the growing number of reported and recorded SNPs; utilizing the sheer number of SNPs data makes it demanding to choose a target for scrutiny which are most likely to contribute to disease development. The dry lab method is a convenient way in these circumstances to distinguish the deleterious SNPs using dedicated algorithms that can discriminate between neutral and deleterious SNPs by examining the databases and combining functional and structural evidence about the ultimate effect of a polymorphism.

The search for missense SNPs in dbSNP against HMGCR resulted in 6815 hits. The rsIDs of which were queried into SIFT and PolyPhen-2 servers. From the total SNPs of HMGCR, we selected only missense type of polymorphism for further investigation as it can have an effect on protein structure. We analyzed 388 missense polymorphisms by employing seven tools to observe how deleterious effect they can exert upon the protein structure (Figure 2). Seven SNPs were predicted deleterious in common in both SIFT and recent studies have found several accounts indicating HMGCR linkage to cholesterol biosynthesis, but there remains a significant amount of polymorphism data on HMGCR that awaits extensive population-based and clinical studies. In this current study, the SNP databases were analyzed to find out SNPs that might potentially be deleterious for HMGCR through the employment of computational methods, Polyphen-2 algorithms. Furthermore, we analyzed the data with several other SNP analyzing algorithms, and in a combined result, also 7 missense SNPs were predicted deleterious. We have employed SIFT, PolyPhen, PMUT, SNAP, PANTHER, MUTPRED, and SNP&GO algorithms to characterize the 388 missense SNPs found available in the database. However, only seven polymorphisms rs112503211, rs113949962, rs147043821, rs147818666, rs148335635, rs193026499, and rs368129510 have shown the deleterious effect upon the protein structure (Figure 3, Tables 1–7). We have employed the InterEvDock2 server to find out the conserveness of the wild residues. We have found these residues are in the conserved region, and if these residues alter, the protein structure would be hampered to initiate its normal activity (Figure 4). The predicted SNPs are located in the SSD and HMG-CoA domains of the protein, which ultimately may hamper the biological activity of HMGCR. Mutations in SSD could be a barrier to sense the sterol for cholesterol regulation into our body (Figure 6). For further analysis, we have explored the protein data bank that contained a structure (3cd5) with 99.8% identity with HMGCR. We performed a free energy calculation of the mutant and wild-type models. The free energy of all the mutated models declined considerably from the wild-type models. We have found all the selected polymorphisms S147, M1, L218, G663, N204, R595, and R159 have shown the protein destability upon the polymorphism except M1 (Figure 5). Further, we have utilized the STRIDE server by which we have observed the structural variation of the mutant models. A mutation may alter the folding pattern of the protein due to change in amino acid with another. Therefore, protein function can be lost ultimately prompting the disease condition. The selected polymorphisms rs112503211 (S147P), rs147043821 (L218F), rs193026499 (R595C), and rs368129510 (R159C) changed the solvent accessible surface area (SASA) and phi and psi angle than the wild-type models. The polymorphism rs147818666 (G663A) did not show any changes in the mutant model. It is to be noted that rs368129510 (R159C) and rs147043821 (L218F) changed in the alpha helix motif whereas rs193026499 (R595C) showed the changes in the beta sheet motif. Therefore, these three polymorphisms rs368129510 (R159C), rs147043821 (L218F), and rs193026499 (R595C) might change the folding pattern and stability of the protein. From the 50 ns molecular dynamic simulation carried out in GROMACS for wild-type HMGCR, rs147043821 and rs193026499, it is clear that these two SNPs have the ability to exert a significant destabilizing effect on the protein and thus disrupt its function (Figures 7 and 8).

In the process of this study, it was observed that despite some correct assumption, the web-based tools need to be more precise in detecting deleterious SNPs and population-based studies are essential to recognize and examine the predicted SNPs in different populations. By cross-referencing all the data from the seven algorithms, we observed two SNPs rs147043821 and rs193026499 have shown the damaging effect in all seven algorithms; therefore, these two could be the most promising polymorphism in the HMGCR.

HMGCR is embedded in the endoplasmic reticulum (ER) membrane. It consists of two distinct domains: N-terminal domain or sterol-sensing domain (SSD) and C-terminal domain or catalytic domain. SSD anchors the protein in ER membrane that senses sterol or cholesterol level in the cell. It either directly or indirectly can sense the intracellular level of sterol/cholesterol. The catalytic domain is protruded in the cytosol and contains all the catalytic activities of HMGCR. The SSD of HMGCR senses the excess level of sterol/cholesterol in the cell, and the sensing result might induce a conformational change in SSD. This causes the protein susceptible to rapid sterol-induced degradation. Whenever there is enough cholesterol present in the cell, HMGCR undergoes proteolysis, and thereby, the quantity of HMGCR is decreased. When SNPs are present in SSD, it may fail to sense intracellular cholesterol levels; as a result, proteolysis of HMGCR does not occur. When present in the catalytic domain, SSD can sense cholesterol level but the further steps of endoplasmic reticulum-associated degradation (ERAD) may be hampered, and hence, catalytic domains fail to be degraded. So, rs147043821 in SSD or rs193026499 in the catalytic domain of HMGCR would hamper feedback regulation and upsurge the hypercholesterolemia, which might be a great concern for health (Figure 9). Though the findings of this study suggest that some SNPs, such as rs147043821 and rs193026499, may cause damage to the HMGCR protein, it is strongly advised that the mutational effect on the structure should be investigated in a wet lab experiment before any conclusive confirmation of their usefulness.

5. Conclusion

The present study analyzed the SNPs of HMGCR gene and predicted seven deleterious SNPs, viz., rs112503211, rs113949962, rs147043821, rs147818666, rs148335635, rs193026499, and rs368129510 through SNP analyzing tools. Among them, rs147043821 and rs193026499 are most likely to have the detrimental effect in the HMGCR gene. Molecular dynamic study also showed that the presence of these two SNPs in the HMGCR gene could have the destabilizing effect in the structure; thus, these SNPs could disrupt the functional effect of the HMGCR gene. Therefore, the results of this study might increase the risk of cholesterol biosynthesis in the human body. However, after the in silico discoveries, wet lab confirmation is required.

Abbreviations

HMGCR:	3-Hydroxy-3-methylglutaryl-CoA reductase
SNPs:	Single nucleotide polymorphisms
LDL:	Low-density lipoprotein
GWAS:	Genome-wide association studies
CVD:	Cardiovascular disease
GO:	Gene Ontology
SASA:	Surface accessibility surface area
SSD:	Sterol-sensing domain.

Data Availability

The datasets analyzed during the current study are available from the corresponding author on reasonable request.

Conflicts of Interest

The authors declare that they do not have competing interests on this work.

Authors’ Contributions

MS and SA conceived, designed, and guided the study; analyzed the data; helped in drafting; and performed critical revision. MUH and MM analyzed the data and helped in drafting the manuscript. KCD helped to design the study, performed bioinformatics analysis, drafted and developed the manuscript, and performed critical revision. All authors have approved the manuscript.

Acknowledgments

This work was supported by the Ministry of Science and Technology under a special research project allocation (grant number MEDI’S-28). We are grateful to the Ministry of Science and Technology for its extensive support.

References

R. Carmena, P. Duriez, and J. C. Fruchart, “Atherogenic lipoprotein particles in atherosclerosis,” Circulation, vol. 109, pp. 2–7, 2004.
View at: Publisher Site | Google Scholar
D. A. Heller, U. de Faire, N. L. Pedersen, G. Dahlén, and G. E. McClearn, “Genetic and environmental influences on serum lipid levels in twins,” The New England Journal of Medicine, vol. 328, no. 16, pp. 1150–1156, 1993.
View at: Publisher Site | Google Scholar
N. P. Kumar, “Calculated low density lipoprotein cholesterol: its relevance in Indian perspective,” Indian Heart Journal, vol. 69, no. 3, pp. 420-421, 2017.
View at: Publisher Site | Google Scholar
I. Crismaru, A. Pantea Stoian, O. Bratu et al., “Low-density lipoprotein cholesterol lowering treatment: the current approach,” Lipids in Health and Disease, vol. 19, no. 1, 2020.
View at: Publisher Site | Google Scholar
H. Park, C. J. Denbow, and C. L. Cramer, “Structure and nucleotide sequence of tomato HMG2 encoding 3-hydroxy-3-methyl-glutaryl coenzyme A reductase,” Plant Molecular Biology, vol. 20, no. 2, pp. 327–331, 1992.
View at: Publisher Site | Google Scholar
J. O. Narita and W. Gruissem, “Tomato hydroxymethylglutaryl-CoA reductase is required early in fruit development but not during ripening,” The Plant Cell, vol. 1, no. 2, pp. 181–190, 1989.
View at: Publisher Site | Google Scholar
S. Ma, W. Sun, L. Gao, and S. Liu, “Therapeutic targets of hypercholesterolemia: HMGCR and LDLR,” Diabetes, metabolic syndrome and obesity: targets and therapy, vol. 12, pp. 1543–1553, 2019.
View at: Publisher Site | Google Scholar
L. Chen, M. Y. Ma, M. Sun et al., “Endogenous sterol intermediates of the mevalonate pathway regulate HMGCR degradation and SREBP-2 processing[S],” Journal of Lipid Research, vol. 60, no. 10, pp. 1765–1775, 2019.
View at: Publisher Site | Google Scholar
S. A. Menzies, N. Volkmar, D. J. van den Boomen et al., “The sterol-responsive RNF145 E3 ubiquitin ligase mediates the degradation of HMG-CoA reductase together with gp78 and Hrd1,” eLife, vol. 7, article e40009, 2018.
View at: Publisher Site | Google Scholar
J. W. Clendening, A. Pandyra, P. C. Boutros et al., “Dysregulation of the mevalonate pathway promotes transformation,” Proceedings of the National Academy of Sciences, vol. 107, no. 34, pp. 15051–15056, 2010.
View at: Publisher Site | Google Scholar
A. Loregger, M. Raaben, J. Tan et al., “Haploid mammalian genetic screen identifies UBXD8 as a key determinant of HMGCR degradation and cholesterol biosynthesis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 37, no. 11, pp. 2064–2074, 2017.
View at: Publisher Site | Google Scholar
A. Endo, “The discovery and development of HMG-CoA reductase inhibitors,” Journal of Lipid Research, vol. 33, no. 11, pp. 1569–1582, 1992.
View at: Publisher Site | Google Scholar
Ž. Reiner, “Statins in the primary prevention of cardiovascular disease,” Nature Reviews. Cardiology, vol. 10, no. 8, pp. 453–464, 2013.
View at: Publisher Site | Google Scholar
J. A. Simon, F. Lin, S. B. Hulley et al., “Phenotypic predictors of response to simvastatin therapy among African- Americans and Caucasians: the cholesterol and pharmacogenetics (CAP) study,” The American Journal of Cardiology, vol. 97, no. 6, pp. 843–850, 2006.
View at: Publisher Site | Google Scholar
Z. Reiner, “Resistance and intolerance to statins,” Nutrition, Metabolism, and Cardiovascular Diseases: NMCD, vol. 24, no. 10, pp. 1057–1066, 2014.
View at: Publisher Site | Google Scholar
G. Schmitz and W. Drobnik, “Pharmacogenomics and pharmacogenetics of cholesterol-lowering therapy,” Clinical Chemistry and Laboratory Medicine, vol. 41, no. 4, pp. 581–589, 2003.
View at: Publisher Site | Google Scholar
M. P. Benjamin, D. I. Chasman, W. Koenig et al., “Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels,” Circulation, vol. 123, no. 7, pp. 731–738, 2011.
View at: Publisher Site | Google Scholar
M. Matarín, W. M. Brown, S. Scholz et al., “A genome-wide genotyping study in patients with ischaemic stroke: initial analysis and data release,” The Lancet. Neurology, vol. 6, no. 5, pp. 414–420, 2007.
View at: Publisher Site | Google Scholar
G. Q. Daley and M. Cargill, “The heart SNPs a beat: polymorphisms in candidate genes for cardiovascular disease,” Trends in Cardiovascular Medicine., vol. 11, no. 2, pp. 60–66, 2001.
View at: Publisher Site | Google Scholar
W. Y. Liu, “Probing the single nucleotide polymorphism (Snp) of swine PPAR delta gene,” Biotechnology(Faisalabad), vol. 12, no. 4, pp. 183–188, 2013.
View at: Publisher Site | Google Scholar
L. M. Steinmetz and R. W. Davis, “Maximizing the potential of functional genomics,” Nature Reviews. Genetics, vol. 5, no. 3, pp. 190–201, 2004.
View at: Publisher Site | Google Scholar
A. Savonarola, R. Palmirotta, F. Guadagni, and F. Silvestris, “Pharmacogenetics and pharmacogenomics: role of mutational analysis in anti- cancer targeted therapy,” The Pharmacogenomics Journal, vol. 12, no. 4, pp. 277–286, 2012.
View at: Publisher Site | Google Scholar
H. Liang, L. W. Cheung, J. Li et al., “Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer,” Genome Research, vol. 22, no. 11, pp. 2120–2129, 2012.
View at: Publisher Site | Google Scholar
M. U. Hossain, M. A. Khan, S. M. Rakib-Uz-Zaman et al., “Treating diabetes mellitus: pharmacophore based designing of potential drugs from Gymnema sylvestre against insulin receptor protein,” BioMed Research International, vol. 2016, Article ID 3187647, 2016.
View at: Publisher Site | Google Scholar
M. Moniruzzaman, M. U. Hossain, M. N. Islam et al., “Coding-complete genome sequence of SARS-CoV-2 isolate from Bangladesh by Sanger sequencing,” Microbiology Resource Announcements, vol. 9, no. 28, article e00626, 2020.
View at: Publisher Site | Google Scholar
M. U. Hossain, T. M. Omar, A. R. Oany et al., “Design of peptide-based epitope vaccine and further binding site scrutiny led to groundswell in drug discovery against Lassa virus,” Biotech, vol. 8, no. 2, p. 81, 2018.
View at: Publisher Site | Google Scholar
A. Bhattacharjee, M. U. Hossain, Z. M. Chowdhury et al., “Insight of druggable cannabinoids against estrogen receptor β in breast cancer,” Journal of Biomolecular Structure & Dynamics, vol. 39, no. 5, pp. 1688–1697, 2021.
View at: Publisher Site | Google Scholar
M. U. Hossain, A. Bhattacharjee, M. Emon et al., “Novel mutations in NSP-1 and PLPro of SARS-CoV-2 NIB-1 genome mount for effective therapeutics,” Journal, Genetic Engineering & Biotechnology, vol. 19, no. 1, 2021.
View at: Publisher Site | Google Scholar
M. U. Hossain, C. A. Keya, K. C. Das et al., “An immunopharmacoinformatics approach in development of vaccine and drug candidates for West Nile virus,” Frontiers in Chemistry, vol. 6, p. 246, 2018.
View at: Publisher Site | Google Scholar
M. U. Hossain, M. A. Khan, A. Hashem et al., “Finding potential therapeutic targets against <i>Shigella flexneri</i> through proteome exploration,” Frontiers in Microbiology, vol. 7, p. 1817, 2016.
View at: Publisher Site | Google Scholar
M. U. Hossain, A. Bhattacharjee, M. Emon et al., “Recognition of plausible therapeutic agents to combat COVID-19: an omics data based combined approach,” Gene, vol. 771, article 145368, 2021.
View at: Publisher Site | Google Scholar
M. Moniruzzaman, I. Ahmed, S. Huq et al., “Association of polymorphism in heat shock protein 70 genes with type 2 diabetes in Bangladeshi population,” Molecular Genetics & Genomic Medicine, vol. 8, no. 2, p. e1073, 2020.
View at: Publisher Site | Google Scholar
M. U. Hossain, A. R. Oany, S. Ahmad, M. A. Hasan, M. A. Khan, and M. Siddikey, “Identification of potential inhibitor and enzyme-inhibitor complex on trypanothione reductase to control Chagas disease,” Computational Biology and Chemistry, vol. 65, pp. 29–36, 2016.
View at: Publisher Site | Google Scholar
T. F. Susmi, A. Rahman, M. Khan et al., “Prognostic and clinicopathological insights of phosphodiesterase 9A gene as novel biomarker in human colorectal cancer,” BMC Cancer, vol. 21, no. 1, p. 577, 2021.
View at: Publisher Site | Google Scholar
M. U. Hossain, A. Hashem, C. A. Keya, and M. Salimullah, “Therapeutics insight with inclusive immunopharmacology explication of human rotavirus A for the treatment of diarrhea,” Frontiers in Pharmacology, vol. 7, p. 153, 2016.
View at: Publisher Site | Google Scholar
A. Kumar, V. Rajendran, R. Sethumadhavan, P. Shukla, S. Tiwari, and R. Purohit, “Computational SNP analysis: current approaches and future prospects,” Cell Biochemistry and Biophysics, vol. 68, no. 2, pp. 233–239, 2014.
View at: Publisher Site | Google Scholar
B. Kamaraj and R. Purohit, “Mutational analysis on membrane associated transporter protein (MATP) and their structural consequences in oculocutaeous albinism type 4 (OCA4)–a molecular dynamics approach,” Journal of Cellular Biochemistry, vol. 117, no. 11, pp. 2608–2619, 2016.
View at: Publisher Site | Google Scholar
B. Kamaraj, V. Rajendran, R. Sethumadhavan, C. V. Kumar, and R. Purohit, “Mutational analysis of FUS gene and its structural and functional role in amyotrophic lateral sclerosis 6,” Journal of Biomolecular Structure and Dynamics, vol. 33, no. 4, pp. 834–844, 2015.
View at: Publisher Site | Google Scholar
A. Kumar and R. Purohit, “Use of long term molecular dynamics simulation in predicting cancer associated SNPs,” PLoS Computational Biology, vol. 10, no. 4, article e1003318, 2014.
View at: Publisher Site | Google Scholar
B. Kamaraj and R. Purohit, “Computational screening of disease-associated mutations in OCA2 gene,” Cell Biochemistry and Biophysics, vol. 68, no. 1, pp. 97–109, 2014.
View at: Publisher Site | Google Scholar
A. Kumar, V. Rajendran, R. Sethumadhavan, and R. Purohit, “Evidence of colorectal cancer-associated mutation in MCAK: a computational report,” Cell Biochemistry and Biophysics, vol. 67, no. 3, pp. 837–851, 2013.
View at: Publisher Site | Google Scholar
A. Kumar, V. Rajendran, R. Sethumadhavan, and R. Purohit, “Roadmap to determine the point mutations involved in cardiomyopathy disorder: a Bayesian approach,” Gene, vol. 519, no. 1, pp. 34–40, 2013.
View at: Publisher Site | Google Scholar
N. L. Sim, P. Kumar, J. Hu, S. Henikoff, G. Schneider, and P. C. Ng, “SIFT web server: predicting effects of amino acid substitutions on proteins,” Nucleic Acids Research, vol. 40, pp. W452–W457, 2012.
View at: Publisher Site | Google Scholar
P. C. Ng and S. Henikoff, “Accounting for human polymorphisms predicted to affect protein function,” Genome Research, vol. 12, no. 3, pp. 436–446, 2002.
View at: Publisher Site | Google Scholar
I. Adzhubei, D. M. Jordan, and S. R. Sunyaev, “Predicting functional effect of human missense mutations using PolyPhen-2,” Current protocols in human genetics, John Wiley, 2013.
View at: Publisher Site | Google Scholar
I. A. Adzhubei, S. Schmidt, L. Peshkin et al., “A method and server for predicting damaging missense mutations,” Nature Methods, vol. 7, no. 4, pp. 248-249, 2010.
View at: Publisher Site | Google Scholar
E. Capriotti and R. B. Altman, “Improving the prediction of disease-related variants using protein three-dimensional structure,” BMC Bioinformatics, vol. 12, no. S4, 2011.
View at: Publisher Site | Google Scholar
E. Capriotti, R. Calabrese, P. Fariselli, P. L. Martelli, R. B. Altman, and R. Casadio, “WS-SNPs&GO: a web server for predicting the deleterious effect of human protein variants using functional annotation,” BMC Genomics, vol. 14, Supplement 3, 2013.
View at: Publisher Site | Google Scholar
H. Tang and P. D. Thomas, “PANTHER-PSEP: predicting disease-causing genetic variants using position-specific evolutionary preservation,” Bioinformatics (Oxford, England), vol. 32, no. 14, pp. 2230–2232, 2016.
View at: Publisher Site | Google Scholar
C. Ferrer-Costa, J. L. Gelpí, L. Zamakola, I. Parraga, X. de la Cruz, and M. Orozco, “PMUT: a web-based tool for the annotation of pathological mutations on proteins,” Bioinformatics, vol. 21, no. 14, pp. 3176–3178, 2005.
View at: Publisher Site | Google Scholar
V. Pejaver, J. Urresti, J. Lugo-Martinez et al., “Inferring the molecular and phenotypic impact of amino acid variants with MutPred2,” Nature Communications, vol. 11, no. 1, p. 5918, 2020.
View at: Publisher Site | Google Scholar
E. Capriotti, P. Fariselli, and R. Casadio, “I-Mutant2.0: predicting stability changes upon mutation from the protein sequence or structure,” Nucleic Acids Research, vol. 33, no. Web Server issue, pp. W306–W310, 2005.
View at: Publisher Site | Google Scholar
E. L. Sonnhammer, S. R. Eddy, E. Birney, A. Bateman, and R. Durbin, “Pfam: multiple sequence alignments and HMM-profiles of protein domains,” Nucleic Acids Research, vol. 26, no. 1, pp. 320–322, 1998.
View at: Publisher Site | Google Scholar
I. Schieferdecker, A. Memon, and H. Washizaki, “Editorial for the special issue of STVR on the 10th IEEE International Conference on Software Testing, Verification, and Validation (ICST 2017),” Software Testing Verification and Reliability, vol. 30, no. 7-8, article e1757, 2020.
View at: Publisher Site | Google Scholar
S. S. Pawar and S. H. Rohane, “Review on discovery studio: an important tool for molecular docking,” Asian Journal Of Research in Chemistry, vol. 14, no. 1, pp. 86–88, 2020.
View at: Google Scholar
J. Söding, A. Biegert, and A. N. Lupas, “The HHpred interactive server for protein homology detection and structure prediction,” Nucleic Acids Research, vol. 33, no. Web Server issue, pp. W244–W248, 2005.
View at: Publisher Site | Google Scholar
L. Bordoli, F. Kiefer, K. Arnold, P. Benkert, J. Battey, and T. Schwede, “Protein structure homology modeling using SWISS-MODEL workspace,” Nature Protocols, vol. 4, no. 1, pp. 1–13, 2009.
View at: Publisher Site | Google Scholar
M. Heinig and D. Frishman, “STRIDE: a web server for secondary structure assignment from known atomic coordinates of proteins,” Nucleic Acids Research, vol. 32, no. Web Server issue, pp. W500–W502, 2004.
View at: Publisher Site | Google Scholar
H. J. Berendsen, D. van der Spoel, and R. van Drunen, “GROMACS: a message-passing parallel molecular dynamics implementation,” Computer Physics Communications, vol. 91, no. 1-3, pp. 43–56, 1995.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2022 Keshob Chandra Das et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

319

Downloads

399

Citations